Ning-ning Zhou

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Combination Treatment With Inhibitors of ERK and Autophagy Enhances Antitumor Activity of Betulinic Acid in Non-small-Cell Lung Cancer In Vivo and In Vitro.

Combination Treatment With Inhibitors of ERK and Autophagy Enhances Antitumor Activity of Betulinic Acid in Non-small-Cell Lung Cancer In Vivo and In Vitro.

Journal: Frontiers in pharmacology

Published: March 23, 2021

Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.

Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 03, 2020

SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.

SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.

Journal: Aging

Published: May 18, 2020

Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.

Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.

Journal: Journal of translational medicine

Published: April 22, 2020

Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation.

Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation.

Journal: Nature communications

Published: January 11, 2019

CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.

CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.

Journal: Cell death & disease

Published: September 04, 2018

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma.

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma.

Journal: OncoTargets and therapy

Published: November 24, 2016

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.

Journal: OncoTargets and therapy

Published: October 06, 2016

Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.

Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.

Journal: The oncologist

Published: January 11, 2016

Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients.

Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: August 21, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026